drugset

drugset / Trial / NCT01756937

Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee

NCT01756937 ↗

Phase 4 Completed 287 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupTriple-blindTreatment

Summary

Efficacy and safety of Imotun capsule in osteoarthritis of the knee

Timeline

Start: 2013-01
Primary completion: 2016-10
Completion: 2017-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Imotun	Unknown	300.03 mg	Oral

Indications